A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT07691307
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Jiangsu Trulive Medical Co., Ltd
- Registry
-
NCT07691307
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07691307. Randomized; no masking; primary purpose treatment. Start 2026-03-18 (actual); primary completion 2028-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
- Condition
- Tricuspid Valve Regurgitation
- Condition
- Tricuspid Valve Insufficiency
- Condition
- Tricuspid Valve Disease
- Intervention (Device)
- TruGamma System
- Intervention (Drug)
- Optimal medical therapy (OMT)
- Lead sponsor
- Jiangsu Trulive Medical Co., Ltd
Record details
- Record id
cardio:ct-nct07691307- Content hash
e48de7c1ad774b0063deb9373300f68a47f968668911a8ce8fbc911ee5cc885c